AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2007
Jan 5, 2007
33341_dirs_2007-01-05_ca787078-32fe-493b-8ccd-82c44d9a5f6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2007-01-05
Reporting Person: RAASCH JONA S (VP & Chief Operations Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-01-05 | Employee Stock Option (Right to Buy) | $22.87 | A | 10363 | Acquired | 2017-01-05 | Common Stock (10363) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64290 | Direct |
| Common Stock | 50 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $11.00 | 2013-06-26 | Common Stock (34091) | 34091 | Direct |
| Employee Stock Option (Right to Buy) | $16.10 | 2014-01-05 | Common Stock (13388) | 13388 | Direct |
| Employee Stock Option (Right to Buy) | $15.46 | 2015-01-05 | Common Stock (15330) | 15330 | Direct |
| Employee Stock Option (Right to Buy) | $17.25 | 2016-01-05 | Common Stock (13739) | 13739 | Direct |
Footnotes
F1: This option becomes fully exercisable on January 5, 2012.
F2: This option becomes fully exercisable on June 26, 2008.
F3: This option becomes fully exercisable on January 5, 2009.
F4: This option becomes fully exercisable on January 5, 2010.
F5: This option becomes fully exercisable on January 5, 2011.
More from NATIONAL RESEARCH CORP
Regulatory Filings
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20